These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 4080962

  • 21. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K, Yonese Y, Nakagami Y, Minowa T, Hiraoka Y, Yamada N, Hikima N, Ishii Y, Tannowa K, Fujioka Y.
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [Abstract] [Full Text] [Related]

  • 22. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
    Ruibal A, Durán P, Lafuerza A, Bodi R, Solé LA, Rubio D, Ibarz L, De Torres JA, Domenech-Torné FM, Salvador L.
    Rev Esp Oncol; 1984 May; 31(3):409-14. PubMed ID: 6546169
    [Abstract] [Full Text] [Related]

  • 23. Serum tumor markers in metastatic breast cancer and course of disease.
    Caffier H, Brandau H.
    Cancer Detect Prev; 1983 May; 6(4-5):451-7. PubMed ID: 6197167
    [Abstract] [Full Text] [Related]

  • 24. [Carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) in the diagnosis of small cell and non-small cell bronchial cancer].
    Schultek T, Wiessmann KJ, Braun J, Wenzel B, Wood WG.
    Prax Klin Pneumol; 1985 Dec; 39(12):962-6. PubMed ID: 3006012
    [No Abstract] [Full Text] [Related]

  • 25. [Changes in the levels of tissue polypeptide antigen and carcinoembryonic antigen in the blood of workers exposed to aromatic amines].
    Lutz W, Krajewska B.
    Med Pr; 1992 Dec; 43(4):297-301. PubMed ID: 1453945
    [Abstract] [Full Text] [Related]

  • 26. [Exposure to asbestos and levels of selected tumor biomarkers].
    Krajewska B, Lutz W, Piłacik B.
    Med Pr; 1996 Dec; 47(2):89-96. PubMed ID: 8657007
    [Abstract] [Full Text] [Related]

  • 27. [Tumor markers in breast cancer].
    Polevaia EB, Tkacheva GA, Letiagin VP, Ivanov VM, Koposova TL.
    Sov Med; 1985 Dec; (3):25-9. PubMed ID: 4023831
    [No Abstract] [Full Text] [Related]

  • 28. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
    Shimizu Y, Oshima K, Nakano Y, Fujita M, Taguchi T.
    Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
    [Abstract] [Full Text] [Related]

  • 29. [Value of the preoperative carcinoembryonic antigen as an independent prognostic factor in cancer of the colon and rectum].
    Young Tabusso F, Payet Meza E, Celis Zapata J, Ruiz Figueroa E, Berrospi Espinoza F.
    Rev Gastroenterol Peru; 2002 Sep; 22(3):213-20. PubMed ID: 12378215
    [Abstract] [Full Text] [Related]

  • 30. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
    Yukawa H, Kono N, Taniguchi K, Ieda K, Ono K, Yamamoto S, Koh K, Ohta M, Hayashido M, Yamaguchi K.
    Nihon Geka Hokan; 1984 Mar 01; 53(2):433-6. PubMed ID: 6508467
    [No Abstract] [Full Text] [Related]

  • 31. [Value of carcinoembryonic antigen (CEA) in the diagnosis and postoperative monitoring of patients with colorectal cancer].
    Catania G, Basile F, Cardì F, Azzarello G, Mazzarino C, Campo M, Giovinetto A.
    Minerva Chir; 1981 May 15; 36(9):569-80. PubMed ID: 6789243
    [No Abstract] [Full Text] [Related]

  • 32. [Comparative morphologic and biochemical determinations of CEA and TPA in invasive breast cancers with special reference to lectin histochemistry and hormone receptor status].
    Vogel J, Oehr P, Totović V, Bellmann O, Dworak O.
    Verh Dtsch Ges Pathol; 1985 May 15; 69():226-31. PubMed ID: 3913197
    [No Abstract] [Full Text] [Related]

  • 33. Postoperative monitoring of CEA in the prediction of surgical outcome in colorectal cancer.
    Smith AN, Gordon A, Browning GC, Williams AE, Sturgeon CM, Seth J.
    J R Coll Surg Edinb; 1985 Oct 15; 30(5):294-8. PubMed ID: 4078776
    [No Abstract] [Full Text] [Related]

  • 34. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R, Albrecht S, Richter B, Deutschmann K, Zimmermann T, Distler W.
    Luminescence; 2000 Oct 15; 15(5):283-9. PubMed ID: 11038485
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Auxiliary value of TPA in diagnosing neoplastic diseases].
    Mizushima Y, Nakamura F, Yokoyama A, Morikage T, Kawasaki S, Hoshino K, Maruyama M, Yamashita N, Yano S.
    Gan No Rinsho; 1986 Jun 15; 32(7):779-82. PubMed ID: 3735675
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Determination of carcinoembryonic antigen in medical practice].
    Graf C, Grob PJ.
    Schweiz Med Wochenschr; 1977 Oct 29; 107(43):1534-7. PubMed ID: 929128
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The clinical significance of tissue polypeptide antigen in breast cancer patients.
    Mross K, Bandlow G.
    Anticancer Res; 1986 Oct 29; 6(2):223-5. PubMed ID: 3707059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.